162 related articles for article (PubMed ID: 34471352)
1. Nanoparticles of a New Small-Molecule P-Selectin Inhibitor Attenuate Thrombosis, Inflammation, and Tumor Growth in Two Animal Models.
Feng Q; Wang M; Muhtar E; Wang Y; Zhu H
Int J Nanomedicine; 2021; 16():5777-5795. PubMed ID: 34471352
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosis.
Bedard PW; Clerin V; Sushkova N; Tchernychev B; Antrilli T; Resmini C; Keith JC; Hennan JK; Kaila N; Debernardo S; Janz K; Wang Q; Crandall DL; Schaub RG; Shaw GD; Carter LL
J Pharmacol Exp Ther; 2008 Feb; 324(2):497-506. PubMed ID: 18024786
[TBL] [Abstract][Full Text] [Related]
3.
Wu J; Zhao M; Wang Y; Wang Y; Zhu H; Zhao S; Gui L; Zhang X; Peng S
Drug Des Devel Ther; 2017; 11():225-239. PubMed ID: 28176928
[TBL] [Abstract][Full Text] [Related]
4. Decreased venous thrombosis with an oral inhibitor of P selectin.
Myers DD; Rectenwald JE; Bedard PW; Kaila N; Shaw GD; Schaub RG; Farris DM; Hawley AE; Wrobleski SK; Henke PK; Wakefield TW
J Vasc Surg; 2005 Aug; 42(2):329-36. PubMed ID: 16102635
[TBL] [Abstract][Full Text] [Related]
5. Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation.
Myers DD; Wrobleski SK; Longo C; Bedard PW; Kaila N; Shaw GD; Londy FJ; Rohrer SE; Fex BA; Zajkowski PJ; Meier TR; Hawley AE; Farris DM; Ballard NE; Henke PK; Schaub RG; Wakefield TW
Thromb Haemost; 2007 Mar; 97(3):400-7. PubMed ID: 17334507
[TBL] [Abstract][Full Text] [Related]
6. Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis.
Myers DD; Henke PK; Bedard PW; Wrobleski SK; Kaila N; Shaw G; Meier TR; Hawley AE; Schaub RG; Wakefield TW
J Vasc Surg; 2006 Sep; 44(3):625-32. PubMed ID: 16950445
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation.
Meier TR; Myers DD; Wrobleski SK; Zajkowski PJ; Hawley AE; Bedard PW; Ballard NE; Londy FJ; Kaila N; Vlasuk GP; Schaub RG; Wakefield TW
Thromb Haemost; 2008 Feb; 99(2):343-51. PubMed ID: 18278184
[TBL] [Abstract][Full Text] [Related]
8. Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine.
Zhang X; Zhang Y; Wang Y; Wu J; Chen H; Zhao M; Peng S
Int J Nanomedicine; 2020; 15():465-481. PubMed ID: 32021191
[TBL] [Abstract][Full Text] [Related]
9. Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis.
Wang Y; Tang J; Zhu H; Jiang X; Liu J; Xu W; Ma H; Feng Q; Wu J; Zhao M; Peng S
Int J Nanomedicine; 2015; 10():6905-18. PubMed ID: 26604756
[TBL] [Abstract][Full Text] [Related]
10. Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent.
Zhu H; Wang Y; Song C; Feng Q; Wu J; Zhao S; Gui L; Zhang X; Zhao M; Peng S
Oncotarget; 2018 Jan; 9(1):268-281. PubMed ID: 29416612
[TBL] [Abstract][Full Text] [Related]
11. A novel lead of P-selectin inhibitor: Discovery, synthesis, bioassays and action mechanism.
Wu J; Zhao M; Wang Y; Wang Y; Zhu H; Zhao S; Peng S
Bioorg Med Chem Lett; 2016 Oct; 26(19):4631-4636. PubMed ID: 27575475
[TBL] [Abstract][Full Text] [Related]
12. P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis.
Ramacciotti E; Myers DD; Wrobleski SK; Deatrick KB; Londy FJ; Rectenwald JE; Henke PK; Schaub RG; Wakefield TW
Thromb Res; 2010 Apr; 125(4):e138-42. PubMed ID: 19962723
[TBL] [Abstract][Full Text] [Related]
13. Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis.
Li S; Wang Y; Wang F; Wang Y; Zhang X; Zhao M; Feng Q; Wu J; Zhao S; Wu W; Peng S
Int J Nanomedicine; 2015; 10():5273-92. PubMed ID: 26345234
[TBL] [Abstract][Full Text] [Related]
14. Effect of PSI-697, a novel P-selectin inhibitor, on platelet-monocyte aggregate formation in humans.
Japp AG; Chelliah R; Tattersall L; Lang NN; Meng X; Weisel K; Katz A; Burt D; Fox KA; Feuerstein GZ; Connolly TM; Newby DE
J Am Heart Assoc; 2013 Jan; 2(1):e006007. PubMed ID: 23525448
[TBL] [Abstract][Full Text] [Related]
15. E-selectin inhibition with GMI-1271 decreases venous thrombosis without profoundly affecting tail vein bleeding in a mouse model.
Culmer DL; Dunbar ML; Hawley AE; Sood S; Sigler RE; Henke PK; Wakefield TW; Magnani JL; Myers DD
Thromb Haemost; 2017 Jun; 117(6):1171-1181. PubMed ID: 28300869
[TBL] [Abstract][Full Text] [Related]
16. Nano-scaled MTCA-KKV: for targeting thrombus, releasing pharmacophores, inhibiting thrombosis and dissolving blood clots in vivo.
Zhao S; Li Z; Huang F; Wu J; Gui L; Zhang X; Wang Y; Wang X; Peng S; Zhao M
Int J Nanomedicine; 2019; 14():4817-4831. PubMed ID: 31308660
[TBL] [Abstract][Full Text] [Related]
17. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions.
Oostingh GJ; Pozgajova M; Ludwig RJ; Krahn T; Boehncke WH; Nieswandt B; Schön MP
Haematologica; 2007 Apr; 92(4):502-12. PubMed ID: 17488661
[TBL] [Abstract][Full Text] [Related]
18. A class of oral N-[(1S,3S)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carbonyl]- N'-(amino-acid-acyl)hydrazine: discovery, synthesis, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and 3D QSAR analysis.
Yao K; Zhao M; Zhang X; Wang Y; Li L; Zheng M; Peng S
Eur J Med Chem; 2011 Aug; 46(8):3237-49. PubMed ID: 21571404
[TBL] [Abstract][Full Text] [Related]
19. P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.
Diaz JA; Wrobleski SK; Alvarado CM; Hawley AE; Doornbos NK; Lester PA; Lowe SE; Gabriel JE; Roelofs KJ; Henke PK; Schaub RG; Wakefield TW; Myers DD
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):829-37. PubMed ID: 25657307
[TBL] [Abstract][Full Text] [Related]
20. Docking based design of diastereoisomeric MTCA as GPIIb/IIIa receptor inhibitor.
Wang X; Wang Y; Wu J; Gui L; Zhang X; Zheng M; Wang Y; Zhao S; Li Z; Zhao M; Peng S
Bioorg Med Chem Lett; 2017 Dec; 27(23):5114-5118. PubMed ID: 29108753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
